サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1746544

日本のeクリニカルソリューション市場レポート：製品別、提供形態別、開発フェーズ別、最終用途別、地域別、2025～2033年

Japan eClinical Solutions Market Report by Product, Delivery Mode (Web-hosted, Licensed Enterprise, Cloud-based), Development Phase, End Use, and Region 2025-2033

出版日
発行
IMARC
ページ情報
英文 119 Pages
納期
5～7営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.08円
日本のeクリニカルソリューション市場レポート：製品別、提供形態別、開発フェーズ別、最終用途別、地域別、2025～2033年
出版日: 2025年06月02日
発行: IMARC
ページ情報: 英文 119 Pages
納期: 5～7営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

日本のeクリニカルソリューション市場規模は2024年に7億2,150万米ドルに達しました。今後、IMARC Groupは、同市場が2033年までに21億3,310万米ドルに達し、2025～2033年にかけて11.7%の成長率（CAGR）を示すと予測しています。同市場は、バイオ製薬企業や製薬企業による研究開発への取り組み、臨床検査におけるソフトウェアソリューションの統合の高まり、安全性モニタリングに対する需要の高まりによって推進されています。

本レポートで扱う主要質問

  • 日本のeクリニカルソリューション市場はこれまでどのように推移し、今後どのように推移するのか？
  • COVID-19が日本のeクリニカルソリューション市場に与えた影響は？
  • 日本のeクリニカルソリューション市場の製品別区分は？
  • 日本のeクリニカルソリューション市場の提供形態別区分は？
  • 日本のeクリニカルソリューション市場の開発フェーズ別区分は？
  • 日本のeクリニカルソリューション市場のエンドユーザー別区分は？
  • 日本のeクリニカルソリューション市場のバリューチェーンにおける各ステージとは？
  • 日本のeクリニカルソリューションの主要な促進要因と課題は何か？
  • 日本のeクリニカルソリューション市場の構造と主要参入企業は？
  • 日本のeクリニカルソリューション市場における競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
  • 市場推定
  • 調査手法

第3章 エグゼクティブサマリー

第4章 日本のeクリニカルソリューション市場-イントロダクション

  • 概要
  • 市場力学
  • 産業動向
  • 競合情報

第5章 日本のeクリニカルソリューション市場情勢

  • 過去と現在の市場動向（2019～2024年）
  • 市場予測（2025～2033年）

第6章 日本のeクリニカルソリューション市場-製品別内訳

  • 電子COA
  • EDCとCDMS
  • 臨床データ統合プラットフォーム
  • 安全ソリューション
  • CTMS
  • RTSM
  • eTMF
  • 臨床分析プラットフォーム

第7章 日本のeクリニカルソリューション市場-提供形態別内訳

  • ウェブホスト（オンデマンド）
  • ライセンスエンタープライズ（オンプレミス）
  • クラウドベース

第8章 日本のeクリニカルソリューション市場-開発フェーズ別内訳

  • フェーズI
  • フェーズII
  • フェーズIII
  • フェーズIV

第9章 日本のeクリニカルソリューション市場-最終用途別内訳

  • 病院
  • 契約研究機関
  • 学術機関
  • 製薬とバイオテクノロジー企業
  • その他

第10章 日本のeクリニカルソリューション市場-競合情勢

  • 概要
  • 市場構造
  • 市場企業のポジショニング
  • 主要成功戦略
  • 競合ダッシュボード
  • 企業評価象限

第11章 主要企業のプロファイル

第12章 日本のeクリニカルソリューション市場-産業分析

  • 促進要因・抑制要因・機会
  • ポーターのファイブフォース分析
  • バリューチェーン分析

第13章 付録

目次
Product Code: SR112025A21699

Japan eClinical solutions market size reached USD 721.5 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 2,133.1 Million by 2033, exhibiting a growth rate (CAGR) of 11.7% during 2025-2033. The market is being propelled by substantial research and development efforts undertaken by biopharmaceutical and pharmaceutical firms, the rising integration of software solutions in clinical trials, and the increasing demand for safety monitoring.

eClinical solutions involve the utilization of technology to manage and analyze clinical data within the realm of clinical research. These solutions play a pivotal role in streamlining the clinical trial process, rendering it more expeditious, efficient, and cost-effective. They encompass a range of tools and systems, including electronic data capture (EDC), clinical trial management systems (CTMS), randomization and trial supply management (RTSM), and electronic patient-reported outcomes (ePRO), among others. These eClinical solutions offer numerous advantages, including enhanced data quality, increased operational efficiency, reduced errors, and improved compliance with regulatory standards. They assist researchers in gaining valuable insights from the data collected during clinical trials, simplifying the identification of trends, outliers, and potential safety concerns.

Japan eClinical Solutions Market Trends:

The market is experiencing significant growth in response to the escalating demand for advanced technological solutions for clinical trial management within Japan. This trend is underscored by the swift adoption of Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS), as well as the increasing reliance on remote patient monitoring and telemedicine, all of which are contributing positively to market expansion. Furthermore, the mounting number of clinical trials and the urgent need for expedited drug development are key drivers propelling market growth. In addition to these factors, there is a growing emphasis on regulatory scrutiny of clinical trial data and a heightened requirement for precise and dependable data, both of which are serving to bolster the market. Furthermore, eClinical solutions are poised to reduce the costs associated with clinical trial management by eliminating paper-based processes and reducing the necessity for manual data entry. This, in turn, is expected to fuel the expansion of the market. Moreover, the market is benefiting from the increasing recognition of patient-centric trials and the rapid adoption of cloud-based solutions. Additionally, the integration of Artificial Intelligence (AI) and Machine Learning (ML) algorithms to discern trends and patterns in data and enhance decision-making is fortifying the market's growth trajectory.

Japan eClinical Solutions Market Segmentation:

Product Insights:

  • eCOA
  • EDC and CDMS
  • Clinical Data Integration Platforms
  • Safety Solutions
  • CTMS
  • RTSM
  • eTMF
  • Clinical Analytics Platforms

Delivery Mode Insights:

  • Web-hosted (On-demand)
  • Licensed Enterprise (On-premises)
  • Cloud-based

Development Phase Insights:

  • Phase I
  • Phase II
  • Phase III
  • Phase IV

End Use Insights:

  • Hospitals
  • Contract Research Organization
  • Academic Institutes
  • Pharma and Biotech Organizations
  • Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

  • How has the Japan eClinical solutions market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan eClinical solutions market?
  • What is the breakup of the Japan eClinical solutions market on the basis of product?
  • What is the breakup of the Japan eClinical solutions market on the basis of delivery mode?
  • What is the breakup of the Japan eClinical solutions market on the basis of development phase?
  • What is the breakup of the Japan eClinical solutions market on the basis of end use?
  • What are the various stages in the value chain of the Japan eClinical solutions market?
  • What are the key driving factors and challenges in the Japan eClinical solutions?
  • What is the structure of the Japan eClinical solutions market and who are the key players?
  • What is the degree of competition in the Japan eClinical solutions market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan eClinical Solutions Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan eClinical Solutions Market Landscape

  • 5.1 Historical and Current Market Trends (2019-2024)
  • 5.2 Market Forecast (2025-2033)

6 Japan eClinical Solutions Market - Breakup by Product

  • 6.1 eCOA
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2019-2024)
    • 6.1.3 Market Forecast (2025-2033)
  • 6.2 EDC and CDMS
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2019-2024)
    • 6.2.3 Market Forecast (2025-2033)
  • 6.3 Clinical Data Integration Platforms
    • 6.3.1 Overview
    • 6.3.2 Historical and Current Market Trends (2019-2024)
    • 6.3.3 Market Forecast (2025-2033)
  • 6.4 Safety Solutions
    • 6.4.1 Overview
    • 6.4.2 Historical and Current Market Trends (2019-2024)
    • 6.4.3 Market Forecast (2025-2033)
  • 6.5 CTMS
    • 6.5.1 Overview
    • 6.5.2 Historical and Current Market Trends (2019-2024)
    • 6.5.3 Market Forecast (2025-2033)
  • 6.6 RTSM
    • 6.6.1 Overview
    • 6.6.2 Historical and Current Market Trends (2019-2024)
    • 6.6.3 Market Forecast (2025-2033)
  • 6.7 eTMF
    • 6.7.1 Overview
    • 6.7.2 Historical and Current Market Trends (2019-2024)
    • 6.7.3 Market Forecast (2025-2033)
  • 6.8 Clinical Analytics Platforms
    • 6.8.1 Overview
    • 6.8.2 Historical and Current Market Trends (2019-2024)
    • 6.8.3 Market Forecast (2025-2033)

7 Japan eClinical Solutions Market - Breakup by Delivery Mode

  • 7.1 Web-hosted (On-demand)
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2019-2024)
    • 7.1.3 Market Forecast (2025-2033)
  • 7.2 Licensed Enterprise (On-premises)
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2019-2024)
    • 7.2.3 Market Forecast (2025-2033)
  • 7.3 Cloud-based
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2019-2024)
    • 7.3.3 Market Forecast (2025-2033)

8 Japan eClinical Solutions Market - Breakup by Development Phase

  • 8.1 Phase I
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2019-2024)
    • 8.1.3 Market Forecast (2025-2033)
  • 8.2 Phase II
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2019-2024)
    • 8.2.3 Market Forecast (2025-2033)
  • 8.3 Phase III
    • 8.3.1 Overview
    • 8.3.2 Historical and Current Market Trends (2019-2024)
    • 8.3.3 Market Forecast (2025-2033)
  • 8.4 Phase IV
    • 8.4.1 Overview
    • 8.4.2 Historical and Current Market Trends (2019-2024)
    • 8.4.3 Market Forecast (2025-2033)

9 Japan eClinical Solutions Market - Breakup by End Use

  • 9.1 Hospitals
    • 9.1.1 Overview
    • 9.1.2 Historical and Current Market Trends (2019-2024)
    • 9.1.3 Market Forecast (2025-2033)
  • 9.2 Contract Research Organization
    • 9.2.1 Overview
    • 9.2.2 Historical and Current Market Trends (2019-2024)
    • 9.2.3 Market Forecast (2025-2033)
  • 9.3 Academic Institutes
    • 9.3.1 Overview
    • 9.3.2 Historical and Current Market Trends (2019-2024)
    • 9.3.3 Market Forecast (2025-2033)
  • 9.4 Pharma and Biotech Organizations
    • 9.4.1 Overview
    • 9.4.2 Historical and Current Market Trends (2019-2024)
    • 9.4.3 Market Forecast (2025-2033)
  • 9.5 Others
    • 9.5.1 Historical and Current Market Trends (2019-2024)
    • 9.5.2 Market Forecast (2025-2033)

10 Japan eClinical Solutions Market - Competitive Landscape

  • 10.1 Overview
  • 10.2 Market Structure
  • 10.3 Market Player Positioning
  • 10.4 Top Winning Strategies
  • 10.5 Competitive Dashboard
  • 10.6 Company Evaluation Quadrant

11 Profiles of Key Players

  • 11.1 Company A
    • 11.1.1 Business Overview
    • 11.1.2 Services Offered
    • 11.1.3 Business Strategies
    • 11.1.4 SWOT Analysis
    • 11.1.5 Major News and Events
  • 11.2 Company B
    • 11.2.1 Business Overview
    • 11.2.2 Services Offered
    • 11.2.3 Business Strategies
    • 11.2.4 SWOT Analysis
    • 11.2.5 Major News and Events
  • 11.3 Company C
    • 11.3.1 Business Overview
    • 11.3.2 Services Offered
    • 11.3.3 Business Strategies
    • 11.3.4 SWOT Analysis
    • 11.3.5 Major News and Events
  • 11.4 Company D
    • 11.4.1 Business Overview
    • 11.4.2 Services Offered
    • 11.4.3 Business Strategies
    • 11.4.4 SWOT Analysis
    • 11.4.5 Major News and Events
  • 11.5 Company E
    • 11.5.1 Business Overview
    • 11.5.2 Services Offered
    • 11.5.3 Business Strategies
    • 11.5.4 SWOT Analysis
    • 11.5.5 Major News and Events

12 Japan eClinical Solutions Market - Industry Analysis

  • 12.1 Drivers, Restraints, and Opportunities
    • 12.1.1 Overview
    • 12.1.2 Drivers
    • 12.1.3 Restraints
    • 12.1.4 Opportunities
  • 12.2 Porters Five Forces Analysis
    • 12.2.1 Overview
    • 12.2.2 Bargaining Power of Buyers
    • 12.2.3 Bargaining Power of Suppliers
    • 12.2.4 Degree of Competition
    • 12.2.5 Threat of New Entrants
    • 12.2.6 Threat of Substitutes
  • 12.3 Value Chain Analysis

13 Appendix